Global Market Analysis Of Veterinary Vaccines Market By Vaccine, By Technology, And By Region (Global Market Forecast To 2027)

Publication Month: Jun 2020 | No. of Pages: 120 Published By: Reports Intellect
Single User License: US $ 3500
Corporate User License: US $ 6500

Market Definition

The Global Veterinary Vaccines market is estimated at $ 7.44 billion in 2019, and expected to reach $ 13.37 billion by 2027, with a CAGR of 7.6% from 2020 to 2027.

Veterinary term mainly relates to the diseases, injuries, and treatment of domestic and farm animals.

A vaccine is one of the most important biological preparations that give active acquired immunity against infectious disease. It is mainly prepared from weakened or killed forms of the microbes, toxins, or its surface proteins.

Types of the vaccines:

  • Live, Attenuated Vaccine
  • Inactivated/Killed Vaccine
  • Toxoid Vaccine
  • Subunit/Conjugate Vaccine

Market Dynamics

The Global Veterinary Vaccines market is primarily driven by factors such as the growing occurrences of zoonotic diseases; growing population of companion animals; growing focus on research and development; growing programs & initiatives by animal associations and government agencies to maintain animal health; growing demand for animal derived food products; growing animal husbandry; technological innovation in the vaccines; growing occurrences of livestock diseases; are some of the market dynamics.

Market Segmentation

The Global Veterinary Vaccines Market is mainly classified based on Vaccine, Technology, and Region.

  • Based on Vaccine, the market is further segmented into Companion Animal Vaccines (Equine Vaccines, Canine Vaccines, and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, and Others)
  • Based on Technology, the market is further segmented into Recombinant Vaccines, Inactivated Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, and Other Vaccines

Regional Analysis

Based on geography, the Global Veterinary Vaccines market is divided into North America, Europe, Asia-Pacific, South America, and Middle East & Africa. North America is further divided into the U.S., Canada, and Mexico, whereas Europe consists of the UK, Germany, France, Italy, and Rest of Europe. Asia-Pacific is categorized into China, Japan, India, South Korea, and Rest of Asia-Pacific. The South America region includes Brazil, Argentina, and the Rest of South America, while the Middle East & Africa is categorized into GCC Countries, Egypt, South Africa, and Rest of Middle East & Africa                                                                                                                      

Reports Intellect Analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Competitive Landscape                     

Global Veterinary Vaccines Market, competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Global Veterinary Vaccines sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2019-2027, this study provides the Global Veterinary Vaccines sales, revenue and market share for each player covered in this report.            

The major players covered in Global Veterinary Vaccines are Zoetis, Boehringer Ingelheim, Ceva, Vetoquinol, Hester Biosciences, Biogenesis Bago, Hipra, Phibro Animal Health, Virbac, Elanco, Merck Animal Health, Jinyu Bio-Technology, Tianjin Ringpu, China Animal Husbandary, Verovaccines, Endovac Animal Health, Indian Immunologicals Ltd., Brilliant Bio Pharma Pvt. Ltd., Torigen, Aptimmune Biologics, and other prominent players.

Veterinary Vaccines Market Key Segments:

By Vaccine         

  • Companion Animal Vaccines
    • Equine Vaccines
    • Canine Vaccines
    • Feline Vaccines
  • Livestock Vaccines
    • Porcine Vaccines
    • Bovine Vaccines
    • Poultry Vaccines
    • Others

By Technology   

  • Recombinant Vaccines
  • Inactivated Vaccines
  • Live Attenuated Vaccines
  • Toxoid Vaccines
  • Other Vaccines

By Region             

  • North America
  • The U.S.A
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • Italy
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • Japan
  • South Korea
  • Rest of Asia Pacific
  • South America
  • Brazil
  • Argentina
  • Rest of South America
  • Middle East & Africa
  • GCC Countries
  • Egypt
  • South Africa
  • Rest of Middle East & Africa

Table of Content

 

1 Market Overview

1.1 Veterinary Vaccines Introduction

1.2 Market Analysis by Vaccine

1.2.1 Overview: Global Veterinary Vaccines Revenue by Vaccine: 2019 VS 2021 VS 2027

1.2.2 Companion Animal Vaccines

1.2.2.1 Equine Vaccines

1.2.2.2 Canine Vaccines

1.2.2.3 Feline Vaccines

1.2.3 Livestock Vaccines

1.2.3.1 Porcine Vaccines

1.2.3.2 Bovine Vaccines

1.2.3.3 Poultry Vaccines

1.2.3.4 Others

1.3 Market Analysis by Technology

1.3.1 Overview: Global Veterinary Vaccines Revenue by Technology: 2019 VS 2021 VS 2027

1.3.2 Recombinant Vaccines 1.3.3 Inactivated Vaccines

1.3.4 Live Attenuated Vaccines

1.3.5 Toxoid Vaccines

 1.3.6 Other Vaccines

1.4 Overview of Global Veterinary Vaccines Market

1.4.1 Global Veterinary Vaccines Market Status and Outlook (2019-2027)

1.4.2 North America (United States, Canada and Mexico)

1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)

1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.5 South America, Middle East & Africa

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

 1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Zoetis

2.1.1 Zoetis Details

2.1.2 Zoetis Major Business and Total Revenue (Financial Highlights) Analysis

2.1.3 Zoetis SWOT Analysis

2.1.4 Zoetis Product and Services

2.1.5 Zoetis Veterinary Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)

2.2 Boehringer Ingelheim

2.2.1 Boehringer Ingelheim Details

2.2.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis

2.2.3 Boehringer Ingelheim SWOT Analysis

2.2.4 Boehringer Ingelheim Product and Services

2.2.5 Boehringer Ingelheim Veterinary Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)

2.3 Ceva

2.3.1 Ceva Details

2.3.2 Ceva Major Business and Total Revenue (Financial Highlights) Analysis

2.3.3 Ceva SWOT Analysis

2.3.4 Ceva Product and Services

2.3.5 Ceva Veterinary Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)

2.4 Vetoquinol 

2.4.1 Vetoquinol Details

2.4.2 Vetoquinol Major Business and Total Revenue (Financial Highlights) Analysis

2.4.3 Vetoquinol SWOT Analysis

2.4.4 Vetoquinol Product and Services

2.4.5 Vetoquinol Veterinary Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)

2.5 Hester Biosciences

2.5.1 Hester Biosciences Details

2.5.2 Hester Biosciences Major Business and Total Revenue (Financial Highlights) Analysis

2.5.3 Hester Biosciences SWOT Analysis

2.5.4 Hester Biosciences on Product and Services

2.5.5 Hester Biosciences Veterinary Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)

2.6 Biogenesis Bago

2.6.1 Biogenesis Bago Details

2.6.2 Biogenesis Bago Major Business and Total Revenue (Financial Highlights) Analysis

2.6.3 Biogenesis Bago SWOT Analysis

2.6.4 Biogenesis Bago Product and Services

2.6.5 Biogenesis Bago Veterinary Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)

2.7 Hipra

2.7.1 Hipra Details

2.7.2 Hipra Major Business and Total Revenue (Financial Highlights) Analysis

2.7.3 Hipra SWOT Analysis

2.7.4 Hipra Product and Services

2.7.5 Hipra Veterinary Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)

2.8 Phibro Animal Health

2.8.1 Phibro Animal Health Details

2.8.2 Phibro Animal Health Major Business and Total Revenue (Financial Highlights) Analysis

2.8.3 Phibro Animal Health SWOT Analysis

2.8.4 Phibro Animal Health Product and Services

2.8.5 Phibro Animal Health Veterinary Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)

2.9 Virbac

2.9.1 Virbac Details

2.9.2 Virbac Major Business and Total Revenue (Financial Highlights) Analysis

2.9.3 Virbac SWOT Analysis

2.9.4 Virbac Product & Services

2.9.5 Virbac Veterinary Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2020) 2.10 Elanco 

2.10.1 Elanco Details

2.10.2 Elanco Major Business and Total Revenue (Financial Highlights) Analysis

2.10.3 Elanco SWOT Analysis

2.10.4 Elanco Product & Services

2.10.5 Elanco Veterinary Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2020) 2.11 Other Players

3 Sales, Revenue and Market Share by Manufacturer

3.1 Global Veterinary Vaccines Sales and Market Share by Manufacturer (2019-2020)

3.2 Global Veterinary Vaccines Revenue and Market Share by Manufacturer (2019-2020)

3.3 Market Concentration Rate

3.3.1 Top 3 Veterinary Vaccines Manufacturer Market Share in 2019 & 2020

3.3.2 Top 6 Veterinary Vaccines Manufacturer Market Share in 2019 & 2020

3.4 Market Competition Trend

4 Global Market Analysis by Regions

4.1 Global Veterinary Vaccines Sales, Revenue and Market Share by Regions

4.1.1 Global Veterinary Vaccines Sales and Market Share by Regions (2019-2020)

4.1.2 Global Veterinary Vaccines Revenue and Market Share by Regions (2019-2020)

4.2 North America Veterinary Vaccines Sales and Growth Rate (2019-2020)

4.3 Europe Veterinary Vaccines Sales and Growth Rate (2019-2020)

4.4 Asia-Pacific Veterinary Vaccines Sales and Growth Rate (2019-2020)

4.5 South America Veterinary Vaccines Sales and Growth Rate (2019-2020)

4.6 Middle East and Africa Veterinary Vaccines Sales and Growth Rate (2019-2020)

5 North America by Country

5.1 North America Veterinary Vaccines Sales, Revenue and Market Share by Country

5.1.1 North America Veterinary Vaccines Sales and Market Share by Country (2019-2020)

5.1.2 North America Veterinary Vaccines Revenue and Market Share by Country (2019-2020)

5.2 United States Veterinary Vaccines Sales and Growth Rate (2019-2020)

5.3 Canada Veterinary Vaccines Sales and Growth Rate (2019-2020)

5.4 Mexico Veterinary Vaccines Sales and Growth Rate (2019-2020)

6 Europe by Country

6.1 Europe Veterinary Vaccines Sales, Revenue and Market Share by Country

6.1.1 Europe Veterinary Vaccines Sales and Market Share by Country (2019-2020)

6.1.2 Europe Veterinary Vaccines Revenue and Market Share by Country (2019-2020)

6.2 Germany Veterinary Vaccines Sales and Growth Rate (2019-2020)

6.3 UK Veterinary Vaccines Sales and Growth Rate (2019-2020)

6.4 France Veterinary Vaccines Sales and Growth Rate (2019-2020)

6.5 Russia Veterinary Vaccines Sales and Growth Rate (2019-2020)

6.6 Italy Veterinary Vaccines Sales and Growth Rate (2019-2020)

7 Asia-Pacific by Regions

7.1 Asia-Pacific Veterinary Vaccines Sales, Revenue and Market Share by Regions

7.1.1 Asia-Pacific Veterinary Vaccines Sales and Market Share by Regions (2019-2020)

7.1.2 Asia-Pacific Veterinary Vaccines Revenue and Market Share by Regions (2019-2020)

7.2 China Veterinary Vaccines Sales and Growth Rate (2019-2020)

7.3 Japan Veterinary Vaccines Sales and Growth Rate (2019-2020)

7.4 Korea Veterinary Vaccines Sales and Growth Rate (2019-2020)

7.5 India Veterinary Vaccines Sales and Growth Rate (2019-2020)

7.6 Southeast Asia Veterinary Vaccines Sales and Growth Rate (2019-2020)

7.7 Australia Veterinary Vaccines Sales and Growth Rate (2019-2020)

8 South America by Country

8.1 South America Veterinary Vaccines Sales, Revenue and Market Share by Country

8.1.1 South America Veterinary Vaccines Sales and Market Share by Country (2019-2020)

8.1.2 South America Veterinary Vaccines Revenue and Market Share by Country (2019-2020)

8.2 Brazil Veterinary Vaccines Sales and Growth Rate (2019-2020)

8.3 Argentina Veterinary Vaccines Sales and Growth Rate (2019-2020)

9 Middle East & Africa by Countries

9.1 Middle East & Africa Veterinary Vaccines Sales, Revenue and Market Share by Country

9.1.1 Middle East & Africa Veterinary Vaccines Sales and Market Share by Country (2019-2020)

9.1.2 Middle East & Africa Veterinary Vaccines Revenue and Market Share by Country (2019-2020)

9.2 Saudi Arabia Veterinary Vaccines Sales and Growth Rate (2019-2020)

9.3 Turkey Veterinary Vaccines Sales and Growth Rate (2019-2020)

9.4 Egypt Veterinary Vaccines Sales and Growth Rate (2019-2020)

9.5 South Africa Veterinary Vaccines Sales and Growth Rate (2019-2020)

10 Global Veterinary Vaccines Market Segment by Vaccine

10.1 Global Veterinary Vaccines Sales Market Share by Vaccine (2019-2020)

10.2 Global Veterinary Vaccines Revenue Market Share by Vaccine (2019-2020)

10.3 Global Veterinary Vaccines Price by Vaccine (2019-2020) 11 Global Veterinary Vaccines Market Segment by Technology

11.1 Global Veterinary Vaccines Sales Market Share by Technology (2019-2020)

11.2 Global Veterinary Vaccines Revenue Market Share by Technology (2019-2020)

11.3 Global Veterinary Vaccines Price by Technology (2019-2020) 12 Market Forecast

12.1 Global Veterinary Vaccines Sales, Revenue and Growth Rate (2021-2027)

12.2 Veterinary Vaccines Market Forecast by Regions (2021-2027)

12.2.1 North America Veterinary Vaccines Market Forecast (2021-2027)

12.2.2 Europe Veterinary Vaccines Market Forecast (2021-2027)

12.2.3 Asia-Pacific Veterinary Vaccines Market Forecast (2021-2027)

12.2.4 South America Veterinary Vaccines Market Forecast (2021-2027)

12.2.5 Middle East & Africa Veterinary Vaccines Market Forecast (2021-2027)

12.3 Veterinary Vaccines Market Forecast by Vaccine (2021-2027)

12.3.1 Global Veterinary Vaccines Sales Forecast by Vaccine (2021-2027)

12.3.2 Global Veterinary Vaccines Market Share Forecast by Vaccine (2021-2027)

12.4 Veterinary Vaccines Market Forecast by Technology (2021-2027)

12.4.1 Global Veterinary Vaccines Sales Forecast by Technology (2021-2027)

12.4.2 Global Veterinary Vaccines Market Share Forecast by Technology (2021-2027)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

15.3 Disclaimer

15.4 About Us

Reason to Buy

  • Current and future of Medical Devices & Consumables Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Medical Devices & Consumables Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Medical Devices & Consumables Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Medical Devices & Consumables Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets